Epilepsy Foundation   Report issue

Foundation Phase 2 Phase 4
Founded: Landover MD United States (1968)

Organization Overview

First Clinical Trial
2008
NCT00835627
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Epilepsy Foundation

Active Ingredients

Drugs in Phase 4 Trials (2)

lamotrigine (lamictal) (2 trials)

sertraline (zoloft) (1 trial)

Drugs in Phase 2 Trials (1)

2-deoxyglucose (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Conversion Disorder (Phase 4)

Disease (Phase 4)

Dissociative Disorders (Phase 4)

Epilepsy (Phase 4)

Hysteria (Phase 4)

Seizures (Phase 4)

Stress Disorders, Post-Traumatic (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 4
  • # of Trial APIs: 3